239 related articles for article (PubMed ID: 32096108)
1. Group A streptococcal bacteremias in Southwest Finland 2007-2018: epidemiology and role of infectious diseases consultation in antibiotic treatment selection.
Vilhonen J; Vuopio J; Vahlberg T; Gröndahl-Yli-Hannuksela K; Rantakokko-Jalava K; Oksi J
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1339-1348. PubMed ID: 32096108
[TBL] [Abstract][Full Text] [Related]
2. A clinical study of beta-haemolytic groups A, B, C and G streptococcal bacteremia in adults over an 8-year period.
Schugk J; Harjola VP; Sivonen A; Vuopio-Varkila J; Valtonen M
Scand J Infect Dis; 1997; 29(3):233-8. PubMed ID: 9255881
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study.
Babiker A; Li X; Lai YL; Strich JR; Warner S; Sarzynski S; Dekker JP; Danner RL; Kadri SS
Lancet Infect Dis; 2021 May; 21(5):697-710. PubMed ID: 33333013
[TBL] [Abstract][Full Text] [Related]
4. Group A streptococcal bacteremia: outcome and prognostic factors.
Vallalta Morales M; Soriano Navarro CJ; Salavert Lletí M; Montero Alonso M; Pérez Bellés C; López Aldeguer J; Otero MC; Gobernado Serrano M
Rev Esp Quimioter; 2006 Dec; 19(4):367-75. PubMed ID: 17235407
[TBL] [Abstract][Full Text] [Related]
5. Clindamycin resistant emm33 Streptococcus pyogenes emerged among invasive infections in Helsinki metropolitan area, Finland, 2012 to 2013.
Pesola AK; Sihvonen R; Lindholm L; Pätäri-Sampo A
Euro Surveill; 2015 May; 20(18):. PubMed ID: 25990232
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics and antimicrobial resistance of invasive group A β-hemolytic streptococcus infection in children].
Fan J; Dong L; Chen Z; Bei D
Zhonghua Er Ke Za Zhi; 2014 Jan; 52(1):46-50. PubMed ID: 24680408
[TBL] [Abstract][Full Text] [Related]
7. Streptococcus bovis revisited: a clinical review of 81 bacteremic episodes paying special attention to emerging antibiotic resistance.
Siegman-Igra Y; Schwartz D
Scand J Infect Dis; 2003; 35(2):90-3. PubMed ID: 12693556
[TBL] [Abstract][Full Text] [Related]
8. Secular trends in incidence of invasive beta-hemolytic streptococci and efficacy of adjunctive therapy in Quebec, Canada, 1996-2016.
Couture-Cossette A; Carignan A; Mercier A; Desruisseaux C; Valiquette L; Pépin J
PLoS One; 2018; 13(10):e0206289. PubMed ID: 30352091
[TBL] [Abstract][Full Text] [Related]
9. Highly virulent M1 Streptococcus pyogenes isolates resistant to clindamycin.
Plainvert C; Martin C; Loubinoux J; Touak G; Dmytruk N; Collobert G; Fouet A; Ploy MC; Poyart C
Med Mal Infect; 2015; 45(11-12):470-4. PubMed ID: 26602794
[TBL] [Abstract][Full Text] [Related]
10. Overwhelming Streptococcus pyogenes sepsis in an elderly patient with septic arthritis.
Chadha A; Jamal W; Aziz ARA; Rotimi VO
J Infect Public Health; 2018; 11(3):434-435. PubMed ID: 28882472
[TBL] [Abstract][Full Text] [Related]
11. Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003.
Sierra JM; Sánchez F; Castro P; Salvadó M; de la Red G; Libois A; Almela M; March F; Español M; Sambeat MA; Romeu J; Brugal MT; de Olalla PG; Gatell JM; Vila J; García F; Colomés JLL; Caylà JA; Coll P
Medicine (Baltimore); 2006 May; 85(3):139-146. PubMed ID: 16721256
[TBL] [Abstract][Full Text] [Related]
12. Six-month multicenter study on invasive infections due to Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis in Argentina.
Lopardo HA; Vidal P; Sparo M; Jeric P; Centron D; Facklam RR; Paganini H; Pagniez NG; Lovgren M; Beall B
J Clin Microbiol; 2005 Feb; 43(2):802-7. PubMed ID: 15695683
[TBL] [Abstract][Full Text] [Related]
13. Genomic Characteristics Behind the Spread of Bacteremic Group A Streptococcus Type emm89 in Finland, 2004-2014.
Latronico F; Nasser W; Puhakainen K; Ollgren J; Hyyryläinen HL; Beres SB; Lyytikäinen O; Jalava J; Musser JM; Vuopio J
J Infect Dis; 2016 Dec; 214(12):1987-1995. PubMed ID: 27707808
[TBL] [Abstract][Full Text] [Related]
14. Temporal trends of β-haemolytic streptococcal osteoarticular infections in western Norway.
Oppegaard O; Skrede S; Mylvaganam H; Kittang BR
BMC Infect Dis; 2016 Oct; 16(1):535. PubMed ID: 27716100
[TBL] [Abstract][Full Text] [Related]
15. Infectious diseases specialist consultation in Staphylococcus lugdunensis bacteremia.
Forsblom E; Högnäs E; Syrjänen J; Järvinen A
PLoS One; 2021; 16(10):e0258511. PubMed ID: 34637480
[TBL] [Abstract][Full Text] [Related]
16. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection.
Zimbelman J; Palmer A; Todd J
Pediatr Infect Dis J; 1999 Dec; 18(12):1096-100. PubMed ID: 10608632
[TBL] [Abstract][Full Text] [Related]
17. Invasive group A streptococcal infections in adults, France (2006-2010).
Plainvert C; Doloy A; Loubinoux J; Lepoutre A; Collobert G; Touak G; Trieu-Cuot P; Bouvet A; Poyart C;
Clin Microbiol Infect; 2012 Jul; 18(7):702-10. PubMed ID: 21883669
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and emm types of invasive group A streptococcal infections in Finland, 2008-2013.
Smit PW; Lindholm L; Lyytikäinen O; Jalava J; Pätäri-Sampo A; Vuopio J
Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2131-6. PubMed ID: 26292935
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic impact of streptococcal and enterococcal bacteremia in hematology patients].
Ombandza-Moussa E; Schlegel L; Vekhoff A; Gerbal R; Marie JP; Bouvet A
Pathol Biol (Paris); 2002 Apr; 50(3):169-77. PubMed ID: 11980330
[TBL] [Abstract][Full Text] [Related]
20. Have group A streptococci with reduced penicillin susceptibility emerged?
Suzuki T; Kimura K; Suzuki H; Banno H; Jin W; Wachino J; Yamada K; Arakawa Y
J Antimicrob Chemother; 2015 Apr; 70(4):1258-9. PubMed ID: 25473026
[No Abstract] [Full Text] [Related]
[Next] [New Search]
